ArticleJournal of thoracic disease2024

Implications for practice: phase II/III trial of carboplatin and irinotecan for elderly patients with extensive-stage small-cell lung cancer in Japan.

Shipra Maheshwari et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.